These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2556280)

  • 1. Relation of in vitro drug activity to clinical response in a prospective trial for advanced germ cell testicular tumors.
    Sanfilippo O; Silvestrini R; Salvioni R; Pizzocaro G
    Eur Urol; 1989; 16(6):450-5. PubMed ID: 2556280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of an in vitro antimetabolic assay to human germ cell testicular tumors for the preclinical evaluation of drug sensitivity.
    Sanfilippo O; Silvestrini R; Zaffaroni N; Piva L; Pizzocaro G
    Cancer; 1986 Oct; 58(7):1441-7. PubMed ID: 3017538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group.
    Fenner M; Oing C; Dieing A; Gauler T; Oechsle K; Lorch A; Hentrich M; Kopp HG; Bokemeyer C; Honecker F
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):717-723. PubMed ID: 30232558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of iproplatin in refractory germ cell tumors: a Southeastern Cancer Study Group trial.
    Drasga RE; Williams SD; Einhorn LH; Birch R
    Cancer Treat Rep; 1987 Sep; 71(9):863-4. PubMed ID: 3040247
    [No Abstract]   [Full Text] [Related]  

  • 5. High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors.
    Lorch A; Rick O; Wündisch T; Hartmann JT; Bokemeyer C; Beyer J
    J Urol; 2010 Jul; 184(1):168-73. PubMed ID: 20483152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group.
    Williams SD; Birch R; Gams R; Irwin L
    Cancer Treat Rep; 1985 Dec; 69(12):1455-6. PubMed ID: 3000593
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of everolimus in refractory testicular germ cell tumors.
    Mego M; Svetlovska D; Miskovska V; Obertova J; Palacka P; Rajec J; Sycova-Mila Z; Chovanec M; Rejlekova K; Zuzák P; Ondrus D; Spanik S; Reckova M; Mardiak J
    Urol Oncol; 2016 Mar; 34(3):122.e17-22. PubMed ID: 26612480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
    Kollmannsberger C; Rick O; Derigs HG; Schleucher N; Schöffski P; Beyer J; Schoch R; Sayer HG; Gerl A; Kuczyk M; Spott C; Kanz L; Bokemeyer C
    J Clin Oncol; 2002 Apr; 20(8):2031-7. PubMed ID: 11956262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of malignant testicular tumors].
    Weissbach L; Jaeger N; Hartlapp JH; Boedefeld EA; Vahlensieck W
    Urologe A; 1983 Sep; 22 Suppl():310-21. PubMed ID: 6314621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of refractory testis cancer: salvage or savage chemotherapy?
    Levine EG; Raghavan D
    Eur J Cancer; 1991; 27(7):932-6. PubMed ID: 1657079
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of post-chemotherapy surgery in germ cell tumors.
    Sim HG; Lange PH; Lin DW
    Urol Clin North Am; 2007 May; 34(2):199-217; abstract ix. PubMed ID: 17484925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of chemotherapy for advanced testicular and extragonadal germ cell tumors: a single-center 27-year experience.
    Tanaka T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T
    Jpn J Clin Oncol; 2010 Jan; 40(1):73-8. PubMed ID: 19773268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germ-cell tumors of the testis: improved results in a prospective study using combined modality therapy and biochemical tumor markers.
    Scardino PT; Skinner DG
    Surgery; 1979 Jul; 86(1):86-93. PubMed ID: 88077
    [No Abstract]   [Full Text] [Related]  

  • 14. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
    Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
    Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of imatinib mesylate in chemotherapy refractory germ cell tumors expressing KIT.
    Einhorn LH; Brames MJ; Heinrich MC; Corless CL; Madani A
    Am J Clin Oncol; 2006 Feb; 29(1):12-3. PubMed ID: 16462496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High-dose chemotherapy with transplantation of autologous stem cells in advanced germ-cell poor-risk testicular tumors].
    May M; Georgieva G; Gunia S; Peter N; Steinhauer HB; Hoschke B
    Urologiia; 2007; (2):58-63. PubMed ID: 17578200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
    Marwaha S; Venner PM; North SA
    Can J Urol; 2007 Oct; 14(5):3692-6. PubMed ID: 17949524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor prognosis germ cell tumors of the testes: improved results with high dose regimens.
    Ozols RF
    Prog Clin Biol Res; 1988; 269():419-27. PubMed ID: 2455910
    [No Abstract]   [Full Text] [Related]  

  • 19. Brief report: phase II multicenter study of temozolomide in patients with cisplatin-resistant germ cell tumors.
    Maroto P; Huddart R; Garcia del Muro X; Horwich A; Paz Ares L; Aparicio J; Germa-Lluch JR
    Oncology; 2011; 80(3-4):219-22. PubMed ID: 21734411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of MDR1-expression in testicular germ cell cancer.
    Schrader AJ; Seger M; Konrad L; Olbert P; Hegele A; Hofmann R; Heidenreich A
    Exp Oncol; 2007 Sep; 29(3):212-6. PubMed ID: 18004247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.